Shilpa Medicare Limited (SHILPAMED.BO)
INR 645.3
(-2.26%)
INR 645.3
(-2.26%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 5.6 Billion INR | 92.75% |
| 2022 | 2.9 Billion INR | -18.07% |
| 2021 | 3.54 Billion INR | -25.44% |
| 2020 | 4.75 Billion INR | 184.7% |
| 2019 | 1.67 Billion INR | 106.07% |
| 2018 | 810.95 Million INR | 19.05% |
| 2017 | 681.18 Million INR | -52.2% |
| 2016 | 1.42 Billion INR | 6771.26% |
| 2015 | 20.73 Million INR | -87.25% |
| 2014 | 162.66 Million INR | -75.89% |
| 2013 | 674.75 Million INR | -4.24% |
| 2012 | 704.65 Million INR | 1288.51% |
| 2011 | 50.74 Million INR | -55.57% |
| 2010 | 114.21 Million INR | -85.16% |
| 2009 | 769.73 Million INR | -31.69% |
| 2008 | 1.12 Billion INR | 27.64% |
| 2007 | 882.82 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 5.58 Billion INR | 0.0% |
| 2023 FY | 5.6 Billion INR | 92.75% |
| 2023 Q4 | 5.6 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q2 | 2.67 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 2.9 Billion INR | 0.0% |
| 2022 FY | 2.9 Billion INR | -18.07% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 4.03 Billion INR | 0.0% |
| 2021 Q4 | 3.54 Billion INR | 0.0% |
| 2021 FY | 3.54 Billion INR | -25.44% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 4.75 Billion INR | 184.7% |
| 2020 Q4 | 4.75 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 3.82 Billion INR | 0.0% |
| 2019 Q2 | 1.27 Billion INR | 0.0% |
| 2019 FY | 1.67 Billion INR | 106.07% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 1.67 Billion INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 810.95 Million INR | 19.05% |
| 2018 Q4 | 810.95 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 622.17 Million INR | 0.0% |
| 2017 FY | 681.18 Million INR | -52.2% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q2 | 1.23 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 681.18 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2016 FY | 1.42 Billion INR | 6771.26% |
| 2016 Q4 | 1.42 Billion INR | 0.0% |
| 2016 Q2 | 260 Thousand INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 20.73 Million INR | -87.25% |
| 2015 Q4 | 20.73 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 1.09 Billion INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 1.2 Billion INR | 0.0% |
| 2014 Q4 | 162.66 Million INR | 0.0% |
| 2014 Q1 | - INR | -100.0% |
| 2014 FY | 162.66 Million INR | -75.89% |
| 2013 Q2 | 721.04 Million INR | 0.0% |
| 2013 FY | 674.75 Million INR | -4.24% |
| 2013 Q4 | 674.75 Million INR | 0.0% |
| 2013 Q3 | - INR | -100.0% |
| 2013 Q1 | - INR | -100.0% |
| 2012 Q2 | 499.82 Million INR | 0.0% |
| 2012 FY | 704.65 Million INR | 1288.51% |
| 2012 Q4 | 704.65 Million INR | 0.0% |
| 2011 FY | 50.74 Million INR | -55.57% |
| 2011 Q4 | 50.74 Million INR | 0.0% |
| 2010 FY | 114.21 Million INR | -85.16% |
| 2009 FY | 769.73 Million INR | -31.69% |
| 2008 FY | 1.12 Billion INR | 27.64% |
| 2007 FY | 882.82 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Bal Pharma Limited | 363.82 Million INR | -1439.645% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Alkem Laboratories Limited | 400 Million INR | -1300.4% |
| Divi's Laboratories Limited | 20 Million INR | -27907.995% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -269.277% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -3694.864% |
| Krebs Biochemicals & Industries Limited | 1.83 Billion INR | -205.264% |
| Mankind Pharma Limited | 248.67 Million INR | -2152.56% |
| Medicamen Biotech Limited | 12.55 Million INR | -44516.479% |
| Medico Remedies Limited | 8.67 Million INR | -64494.084% |
| Megasoft Limited | 1.35 Billion INR | -312.772% |
| Procter & Gamble Health Limited | 68.8 Million INR | -8041.859% |
| Piramal Pharma Limited | 24.83 Billion INR | 77.447% |
| Sequent Scientific Limited | 1.42 Billion INR | -292.491% |
| Sigachi Industries Limited | 265.79 Million INR | -2007.465% |
| Ajanta Pharma Limited | 235.2 Million INR | -2281.632% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -42017.286% |
| Brooks Laboratories Limited | 3.56 Million INR | -157027.602% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -1400299.75% |
| Themis Medicare Limited | 267.74 Million INR | -1992.179% |
| Unichem Laboratories Limited | 382.22 Million INR | -1365.539% |
| Hester Biosciences Limited | 1.81 Billion INR | -208.165% |
| Venus Remedies Limited | 386.8 Million INR | -1348.19% |
| Indoco Remedies Limited | 3.51 Billion INR | -59.258% |
| Ind-Swift Limited | 10.09 Billion INR | 44.511% |
| Aarti Drugs Limited | 2.75 Billion INR | -103.45% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -20023.577% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 6.484% |
| Granules India Limited | 689.71 Million INR | -712.167% |
| Gufic Biosciences Limited | 1.53 Billion INR | -263.827% |
| Hikal Limited | 4.22 Billion INR | -32.472% |
| RPG Life Sciences Limited | -30.3 Million INR | 18587.125% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -2537.834% |
| Windlas Biotech Limited | 20.18 Million INR | -27658.171% |
| ZIM Laboratories Limited | 356 Million INR | -1473.456% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -4918.185% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 82.313% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 73.762% |
| Bajaj HealthCare Limited | 650.34 Million INR | -761.327% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Ipca Laboratories Limited | 5.8 Billion INR | 3.489% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Laurus Labs Limited | 8.6 Billion INR | 34.895% |
| NATCO Pharma Limited | 53 Million INR | -10469.055% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -299.234% |
| Solara Active Pharma Sciences Limited | 1.05 Billion INR | -429.302% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 65.077% |
| Wanbury Limited | 820 Million INR | -583.122% |
| Wockhardt Limited | 8.91 Billion INR | 37.131% |
| Strides Pharma Science Limited | 6.71 Billion INR | 16.581% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -1473.828% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -40003.086% |
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -790.84% |
| Eris Lifesciences Limited | 6.54 Billion INR | 14.415% |
| Lupin Limited | 1.55 Billion INR | -260.742% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -5154.783% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 459624.118% |
| Valiant Laboratories Limited | 746.63 Million INR | -650.251% |
| Zydus Lifesciences Limited | 251 Million INR | -2131.713% |
| FDC Limited | 2.46 Million INR | -227053.244% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -2269.543% |
| Novartis India Limited | 50.7 Million INR | -10948.519% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -7312.464% |
| Neuland Laboratories Limited | 449.2 Million INR | -1147.0% |
| Morepen Laboratories Limited | 33.64 Million INR | -16551.602% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -4094.666% |